港股異動 | 特步國際(1368.HK)漲逾11% 股價續創新高
格隆匯6月17日丨特步國際(1368.HK)股價延續近期強勢,現報12港元續創新高,漲幅11.5%,最新總市值314.64億港元,月內累計漲幅超40%。公司15日公吿稱,向高瓴發行5億元可換股債券,按初步換股價悉數轉換可換股債券後,將發行最高5436.2萬股換股股份,相當於公司現有已發行股本約2.07%及經發行換股股份擴大後已發行股本2.03%。浙商證券指,在整個體育服飾行業高速增長的大背景下,認為在公司15年長期耕耘跑步奠定的基礎下,高瓴的加入有望讓公司獲得更多的行業資源,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.